BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
90 results:

  • 1. Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma.
    Masoud SJ; Rhodin KE; Kanu E; Bao J; Eckhoff AM; Bartholomew AJ; Howell TC; Aykut B; Kosovec JE; Palta M; Befera NT; Kim CY; Herbert G; Shah KN; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Lidsky ME
    Ann Surg Oncol; 2023 Oct; 30(11):6639-6646. PubMed ID: 37436606
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of Metabolic Syndrome and Fatty liver Diseases in Gastric cancer Survivors: A Propensity Score-Matched Analysis.
    Han SJ; Baik SJ; Yoon YH; Kim JH; Lee HS; Jeon S; Park H
    Korean J Gastroenterol; 2023 Apr; 81(4):154-162. PubMed ID: 37096435
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Contrast-enhanced CT parameters predict short-term tumor response in patients with hepatocellular carcinoma who received sequential combined anti-angiogenesis and immune checkpoint inhibitor treatment.
    Feng Y; Zhang H; Ren Q; Li C; Liu S; Zheng C; Xia X
    Eur J Radiol; 2023 May; 162():110784. PubMed ID: 36958125
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
    Qi W; Yang J; Zheng L; Lu Y; Liu R; Ju Y; Niu T; Wang D
    Med Phys; 2023 May; 50(5):2705-2714. PubMed ID: 36841949
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of combined pre- and postoperative albumin-to-alkaline phosphatase ratio for patients with hepatocellular carcinoma undergoing trans-catheter chemoembolisation.
    Li J; Yang S; Li C; Zhu G; Xia J
    Clin Radiol; 2023 Apr; 78(4):301-309. PubMed ID: 36690510
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol.
    Carlsson MJ; Vollmer AS; Demuth P; Heylmann D; Reich D; Quarz C; Rasenberger B; Nikolova T; Hofmann TG; Christmann M; Fuhlbrueck JA; Stegmüller S; Richling E; Cartus AT; Fahrer J
    Cell Death Dis; 2022 Nov; 13(11):1009. PubMed ID: 36446765
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Delayed biopsy following completion of transarterial chemoembolization in patients with hepatocellular carcinoma: Effects on pathological outcomes and its advantages.
    Zhi W; Hou J; Fan S; Han Y
    J Cancer Res Ther; 2022 Sep; 18(5):1346-1351. PubMed ID: 36204882
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. BI6727, a polo-like kinase 1 inhibitor, synergizes with gefitinib to suppress hepatocellular carcinoma cells via a G2/M arrest mechanism.
    Zhou Q; Chen T
    Pharmazie; 2022 Sep; 77(7):230-235. PubMed ID: 36199185
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney cancer Consortium (TKCC) Database.
    Yekedüz E; Karakaya S; Ertürk İ; Tural D; Uçar G; Şentürk Öztaş N; Arıkan R; Hızal M; Küçükarda A; Sever ÖN; Arslan Ç; Can O; Kılıçkap S; Yazgan C; Karadurmuş N; Şendur MA; Çiçin İ; Demirci U; Özgüroğlu M; Öksüzoğlu B; Ürün Y
    Clin Genitourin Cancer; 2023 Feb; 21(1):175-182. PubMed ID: 35970759
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. p53 as a unique target of action of cisplatin in acute leukaemia cells.
    Kumar S; Tchounwou PB
    J Cell Mol Med; 2022 Sep; 26(17):4727-4739. PubMed ID: 35946055
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prediction Model and Nomogram of Early Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation Based on Logistic Regression Analysis.
    Ni Z; Wu B; Li M; Han X; Hao X; Zhang Y; Cheng W; Guo C
    Ultrasound Med Biol; 2022 Sep; 48(9):1733-1744. PubMed ID: 35690523
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia.
    Aslan B; Kismali G; Iles LR; Manyam GC; Ayres ML; Chen LS; Gagea M; Bertilaccio MTS; Wierda WG; Gandhi V
    Blood Cancer J; 2022 May; 12(5):80. PubMed ID: 35595730
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genotoxicity, oxidative stress and transcriptomic effects of Nitenpyram on human bone marrow mesenchymal stem cells.
    Liu W; Li Z; Cui X; Luo F; Zhou C; Zhang J; Xing L
    Toxicol Appl Pharmacol; 2022 Jul; 446():116065. PubMed ID: 35568224
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Multivariate analysis of the effect of two liver resection methods on the survival outcome of patients with intrahepatic cholangiocarcinoma].
    Han XS; Li QW; Guo PL; Li JJ
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(18):1364-1368. PubMed ID: 35545580
    [No Abstract]    [Full Text] [Related]  

  • 15. Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells.
    Hamaya S; Fujihara S; Iwama H; Fujita K; Shi T; Nakabayashi R; Mizuo T; Takuma K; Nakahara M; Oura K; Tadokoro T; Mimura S; Tani J; Morishita A; Kobara H; Ono M; Himoto T; Masaki T
    Anticancer Res; 2022 Mar; 42(3):1263-1275. PubMed ID: 35220216
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Repression of CRNDE enhances the anti-tumour activity of CD8 + T cells against oral squamous cell carcinoma through regulating miR-545-5p and TIM-3.
    Ai Y; Wu S; Gao H; Wei H; Tang Z; Li X; Zou C
    J Cell Mol Med; 2021 Dec; 25(23):10857-10868. PubMed ID: 34729919
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting CDC7 potentiates atr-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer.
    Guo Y; Wang J; Benedict B; Yang C; van Gemert F; Ma X; Gao D; Wang H; Zhang S; Lieftink C; Beijersbergen RL; Te Riele H; Qiao X; Gao Q; Sun C; Qin W; Bernards R; Wang C
    Genome Med; 2021 Oct; 13(1):166. PubMed ID: 34663432
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Oxymestane, a cytostatic steroid derivative of exemestane with greater antitumor activity in non-estrogen-dependent cell lines.
    Pires AS; Varela CL; Marques IA; Abrantes AM; Gonçalves C; Rodrigues T; Matafome P; Botelho MF; Roleira FMF; Tavares-da-Silva E
    J Steroid Biochem Mol Biol; 2021 Sep; 212():105950. PubMed ID: 34271024
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Live-cell atr-FTIR spectroscopy as a novel bioanalytical tool for cell glucose metabolism research.
    Poonprasartporn A; Chan KLA
    Biochim Biophys Acta Mol Cell Res; 2021 Jun; 1868(7):119024. PubMed ID: 33831457
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Daphnegiravone D from Daphne giraldii induces cell death by targeting atr in Hep3B cells.
    Shang XY; Yu XQ; Yao GD; Song SJ
    Bioorg Chem; 2021 May; 110():104802. PubMed ID: 33730672
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.